| (Values in U.S. Thousands) | Dec, 2022 | Dec, 2021 | Dec, 2020 | Dec, 2019 | Feb, 2026 |
| Sales | 16,760 | 17,260 | 10,390 | 7,510 | 0 |
| Sales Growth | -2.90% | +66.12% | +38.35% | unch | unch |
| Net Income | -106,000 | -81,570 | -23,260 | -13,630 | 0 |
| Net Income Growth | -29.95% | -250.69% | -70.65% | unch | unch |
Isoplexis Corp
(ISO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
IsoPlexis Corporation is a life science technology company which build solutions for development of curative medicines and personalized therapeutics. IsoPlexis Corporation is based in BRANFORD, Conn.
Fiscal Year End Date: 12/31